Loading clinical trials...
Loading clinical trials...
Use of Novel Self-assembling RADA-16 Peptide Matrix to Decrease Postoperative Epistaxis for Tonsillectomy Surgeries
Conditions
Interventions
RADA16 hydrogel
Locations
2
United States
Cooperman Barnabas Medical Center
Livingston, New Jersey, United States
University Hospital
Newark, New Jersey, United States
Start Date
September 12, 2025
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
April 21, 2026
NCT07547774
NCT07058727
NCT06862609
NCT07436806
NCT07327463
NCT07461467
Lead Sponsor
Rutgers, The State University of New Jersey
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions